Thalidomide Prevention or Treatment of Camrelizumab-induced Reactive Cutaneous Capillary Endothelial Proliferation (RCCEP)
Henan Cancer Hospital
Henan Cancer Hospital
Fujian Cancer Hospital
Haihe Biopharma Co., Ltd.
ChineseAMS
The First People's Hospital of Hefei
Changzhou No.2 People's Hospital
Zhengzhou University
National Cancer Institute (NCI)
The First Affiliated Hospital of Xiamen University
Fudan University
National Cheng-Kung University Hospital
Sun Yat-sen University
National Taiwan University Hospital
National Center for Research Resources (NCRR)